Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis
- PMID: 15753539
- PMCID: PMC1774444
- DOI: 10.1136/gut.2003.036558
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis
Abstract
Background: Antinuclear antibodies (ANA) giving a rim-like/membranous (RL/M) or a multiple nuclear dot (MND) pattern are highly specific for primary biliary cirrhosis (PBC). Aim and
Subjects: To assess the prevalence of PBC specific ANAs, their Ig isotype, and their clinical significance in 90 PBC patients from Greece and Spain. Twenty eight patients with chronic hepatitis C, 23 patients with systemic lupus erythematosus, and 17 healthy subjects were studied as controls.
Methods: PBC specific ANA reactivity was tested by indirect immunofluorescence using HEp2 cells as substrate and individual Ig class (IgG, IgA, IgM) and IgG subclass (IgG1, IgG2, IgG3, IgG4) specific antisera as revealing reagents.
Results: Fourteen of 90 (15.6%) PBC patients had PBC specific ANA reactivity when an anti-IgG (total) antiserum was used as the revealing reagent while 58 (64.4%) were positive when specific antisera to each of the four IgG isotypes were used. The prevailing isotype was IgG3 for MND and IgG1 for RL/M. PBC patients with specific ANA, in particular of the IgG3 isotype, had significantly more severe biochemical and histological disease compared with those who were seronegative. None of the controls was positive.
Conclusions: Disease specific ANA are present in the majority of patients with PBC when investigated at the level of immunoglobulin isotype. PBC specific ANA, in particular of the IgG3 isotype, are associated with a more severe disease course, possibly reflecting the peculiar ability of this isotype to engage mediators of damage.
Figures


Similar articles
-
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis.Autoimmunity. 2009 Mar;42(3):224-7. doi: 10.1080/08916930802709133. Autoimmunity. 2009. PMID: 19301204
-
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.Liver Int. 2007 Nov;27(9):1226-31. doi: 10.1111/j.1478-3231.2007.01586.x. Liver Int. 2007. PMID: 17919234
-
Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.Hepatogastroenterology. 1996 Sep-Oct;43(11):1135-40. Hepatogastroenterology. 1996. PMID: 8908541
-
Antinuclear antibodies in primary biliary cirrhosis.Semin Liver Dis. 2005 Aug;25(3):298-310. doi: 10.1055/s-2005-916321. Semin Liver Dis. 2005. PMID: 16143945 Review.
-
The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.Clin Chem Lab Med. 2017 Nov 27;56(1):25-31. doi: 10.1515/cclm-2017-0249. Clin Chem Lab Med. 2017. PMID: 28731850 Review.
Cited by
-
Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.Gastroenterol Res Pract. 2019 Jun 10;2019:8959103. doi: 10.1155/2019/8959103. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31281353 Free PMC article.
-
Hellenic Association for the Study of the Liver (HASL): revised clinical practice guidelines for autoimmune hepatitis.Ann Gastroenterol. 2024 Nov-Dec;37(6):623-654. doi: 10.20524/aog.2024.0924. Epub 2024 Oct 24. Ann Gastroenterol. 2024. PMID: 39568707 Free PMC article.
-
Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?J Transl Int Med. 2021 Mar 31;9(1):43-51. doi: 10.2478/jtim-2021-0008. eCollection 2021 Mar. J Transl Int Med. 2021. PMID: 33850801 Free PMC article.
-
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.J Autoimmun. 2015 Feb;57:1-13. doi: 10.1016/j.jaut.2014.12.002. Epub 2015 Jan 9. J Autoimmun. 2015. PMID: 25578468 Free PMC article. Review.
-
Update on primary biliary cirrhosis.Dig Liver Dis. 2010 Jun;42(6):401-8. doi: 10.1016/j.dld.2010.02.014. Epub 2010 Mar 31. Dig Liver Dis. 2010. PMID: 20359968 Free PMC article. Review.
References
-
- Neuberger J. Primary biliary cirrhosis. Lancet 1997;350:875–9. - PubMed
-
- Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003;7:759–77. - PubMed
-
- Vergani D, Bogdanos DP. Positive markers in AMA-negative PBC. Am J Gastroenterol 2003;98:241–3. - PubMed
-
- Szostecki C, Guldner HH, Will H. Autoantibodies against “nuclear dots” in primary biliary cirrhosis. Semin Liver Dis 1997;17:71–8. - PubMed
-
- Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:79–90. - PubMed